NCT07610876

Brief Summary

This randomized clinical study aims to evaluate the effect of autologous demineralized dentin graft (ADDG) with or without melatonin gel on the osseointegration of immediately placed dental implants in the maxillary premolar region. Sixteen patients requiring extraction and immediate implant placement will be randomly allocated into two groups. Clinical and radiographic outcomes including implant stability, peri-implant probing depth, modified bleeding index, marginal bone loss, buccal bone thickness, and bone density will be evaluated over a 9-month follow-up period.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Aug 2025Nov 2026

Study Start

First participant enrolled

August 11, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 20, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 28, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2026

Last Updated

May 28, 2026

Status Verified

May 1, 2026

Enrollment Period

1.2 years

First QC Date

May 20, 2026

Last Update Submit

May 20, 2026

Conditions

Keywords

MelatoninDentin graftImmediate implantADDGOsseointegrationCBCTDental implant stability

Outcome Measures

Primary Outcomes (4)

  • Implant Stability Quotient (ISQ)

    Measured using Penguin device immediately after implant placement and after 6 months.

    Baseline and 6 months

  • Jumping Distance

    The horizontal bucco-implant gap (jumping distance) will be measured radiographically using CBCT at 0 mm, 2 mm, and 5 mm apical to the implant shoulder as the perpendicular distance from the implant surface to the inner buccal bone plate.

    Immediate postoperative and 9 months after implant placement

  • Marginal Bone Loss

    Marginal bone loss will be assessed radiographically using cone beam computed tomography (CBCT) as the vertical distance from the implant platform to the alveolar crest around the implant.

    Immediate postoperative and 9 months after implant placement

  • Bone Density

    Bone density around the implant will be measured radiographically using CBCT and expressed in Hounsfield units (HU) to evaluate peri-implant bone maturation and osseointegration.

    Immediate postoperative and 9 months after implant placement

Secondary Outcomes (4)

  • Buccal Bone Thickness (BBT)

    Preoperative, immediate postoperative, and 9 months after implant placement

  • Buccal Bone Height (BBH)

    Preoperative, immediate postoperative, and 9 months after implant placement

  • Peri-Implant Sulcus Depth (PISD)

    Baseline, 6 months, and 9 months

  • Modified Bleeding on Probing Index (MBOP)

    Baseline, 6 months, and 9 months

Study Arms (2)

ADDG Alone

EXPERIMENTAL

Participants in this arm will receive immediate implant placement in the maxillary premolar region with jumping gap filling using autologous demineralized dentin graft (ADDG) alone after extraction of non-restorable teeth. Clinical and radiographic evaluation will be performed during the follow-up period.

Procedure: Autologous Demineralized Dentin Graft

ADDG + Melatonin Gel

EXPERIMENTAL

Participants in this arm will receive immediate implant placement in the maxillary premolar region with jumping gap filling using autologous demineralized dentin graft (ADDG) mixed with melatonin gel after extraction of non-restorable teeth. Clinical and radiographic evaluation will be performed during the follow-up period.

Drug: Melatonin gel

Interventions

Autologous demineralized dentin graft prepared from extracted non-restorable teeth will be used for filling the jumping gap around immediately placed dental implants. Tooth preparation includes removal of restorations, caries, periodontal ligament, pulp tissue, calculus, and cementum, followed by grinding and demineralization using 2% nitric acid before graft placement.

ADDG Alone

Melatonin gel will be mixed with autologous demineralized dentin graft and used for filling the jumping gap around immediately placed dental implants in the maxillary premolar region to enhance osseointegration and peri-implant bone healing.

ADDG + Melatonin Gel

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age above 20 years
  • Non-restorable maxillary premolar teeth
  • Candidates for immediate implant placement
  • Intact socket walls
  • Jumping gap \>2 mm
  • Non-smokers or light smokers
  • No acute infection
  • Adequate bone for primary stability

You may not qualify if:

  • Heavy smokers
  • Bruxism or clenching
  • Uncontrolled systemic disease
  • Chemotherapy/radiotherapy
  • Immunocompromised patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Suez Canal University, Faculty of Dentistry

Ismailia, Egypt

RECRUITING

Study Officials

  • Hany Kamel Shalaby

    Professor of Oral Medicine and Periodontology, Dean Faculty of Dentistry

    STUDY CHAIR
  • Shaima Mohammed Morsy

    Assistant Professor of Oral Medicine and Periodontology

    STUDY DIRECTOR
  • Rasha El-Sayed Afifi

    Lecturer of Oral Medicine and Periodontology

    STUDY DIRECTOR
  • Abd El Fattah ELSaid Attia, B.S.D

    B.S.D

    PRINCIPAL INVESTIGATOR

Central Study Contacts

B.S.D Abd El Fattah ELSaid Attia

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Abd El Fattah ELSaid Attia Mowafy

Study Record Dates

First Submitted

May 20, 2026

First Posted

May 28, 2026

Study Start

August 11, 2025

Primary Completion (Estimated)

October 10, 2026

Study Completion (Estimated)

November 10, 2026

Last Updated

May 28, 2026

Record last verified: 2026-05

Locations